Effect of lithium carbonate on zidovudine-associated neutropenia in the acquired immunodeficiency syndrome.
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000188:drug therapy*; D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D006801:Humans; D007958:Leukocyte Count; D008094:Lithium / Q000627:therapeutic use*; D016651:Lithium Carbonate; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced*; D009504:Neutrophils / Q000187:drug effects; D013936:Thymidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D015215:Zidovudine
D016651:Lithium Carbonate; D015215:Zidovudine; D008094:Lithium; D013936:Thymidine